Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage

Neurosurgery

Volumn 46, Issue 5, 2000, Pages 1193-1203

  Stoodley, Marcus ^a   Weihl, Conrad C ^a   Zhang, Zhen Du ^a   Lin, George ^a   Johns, Lydia M ^a   Kowalczuk, Andrew ^a   Ghadge, Ghanashayam ^a   Roos, Raymond P ^a   Macdonald, R Loch ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Cerebral vasospasm; Dog; Gene therapy; Nitric oxide; Nitric oxide synthase; Subarachnoid hemorrhage

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOG; GENE THERAPY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBARACHNOID HEMORRHAGE; TRANSGENE; VASODILATATION;

EID: 0034100556     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200005000-00034     Document Type: Article

References (40)

1. Afshar JK, Pluta RM, Boock RJ, Thompson BG, Oldfield EH: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118-122, 1995.
2. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski MR: Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3:224-228, 1993.
3. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A: Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 3:229-234, 1993.
4. Borgos J: Doppler monitoring of cerebral blood flow. Neurol Res 18:251-255, 1996.
5. Bredt DS, Snyder SH: Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem 63:175-195, 1994.
6. Byrnes AP, MacLaren RE, Charlton HM: Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J Neurosci 16:3045-3055, 1996.
7. Chen AF, Jiang SW, Crotty TB, Tsutsui M, Smith LA, O'Brien T, Katusic ZS: Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Nat Acad Sci U S A 94:12568-12573, 1997.
8. Chen AF, O'Brien T, Tsutsui M, Kinoshita H, Pompili VJ, Crotty TB, Spector DJ, Katusic ZS: Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. Circ Res 80:327-335, 1997.
9. Christenson SD, Lake KD, Ooboshi H, Farad FM, Davidson BL, Heistad DD: Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice. Stroke 29:1411-1416, 1998.
10. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ: A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 3:219-223, 1993.
11. Egemen N, Turker RK, Sanlidilek U, Zorlutuna A, Bilgic S, Baskaya M, Unlu A, Caglar S, Spetzler RF, McCormick JM: The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res 15:310-315, 1993.
12. Faraci FM, Heistad DD: Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiol Rev 78:53-97, 1998.
13. Frazee JG, Giannotta SL, Stern WE: Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate. J Neurosurg 55:865-868, 1981.
14. Hongo K, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Ogawa H, Vollmer DG, Lehman RM: Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg 69:247-253, 1988.
15. Jordan J, Ghadge GD, Prehn JH, Toth PT, Roos RP, Miller RJ: Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor. Mol Pharmacol 47:1095-1100, 1995.
16. Kanamaru K, Weir BK, Findlay JM, Krueger CA, Cook DA: Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage. J Neurosurg 71:909-915, 1989.
17. Kantor DB, Lanzrein M, Stary SJ, Sandoval GM, Smith WB, Sullivan BM, Davidson N, Schuman EM: A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue. Science 274:1744-1748, 1996.
18. Kim P, Schini VB, Sundt TM Jr, Vanhoutte PM: Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 70:248-256, 1992.
19. Kistler JP, Lees RS, Candia G, Zervas NT, Crowell RM, Ojemann RG: Intravenous nitroglycerin in experimental cerebral vasospasm: A preliminary report. Stroke 10:26-29, 1979.
20. Kullo IJ, Mozes G, Schwartz RS, Gloviczki P, Crotty TB, Barber DA, Katusic ZS, O'Brien T: Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity. Circulation 96:2254-2261, 1997.
21. Kullo IJ, Schwartz RS, Pompili VJ, Tsutsui M, Milstien S, Fitzpatrick LA, Katusic ZS, O'Brien T: Expression and function of recombinant endothelial NO synthase in coronary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 17:2405-2412, 1997.
22. Le Gal Le Salle G, Roberts JJ, Berrard S, Ridoux V, StratfordPerricaudet LD, Perricaudet M, Mallet J: An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990, 1993.
23. Deleted in proof.
24. Macdonald RL, Weir BK: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991.
25. Macdonald RL, Wang X, Zhang J, Marton LS: Molecular changes with subarachnoid hemorrhage and vasospasm, in Raffel C, Harsh GR (eds): The Molecular Basis of Neurosurgical Disease. Baltimore, Williams & Wilkins, 1996, pp 278-295.
26. Manno EM, Gress DR, Ogilvy CS, Stone CM, Zervas NT: The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: A pilot study. Neurosurgery 40:289-293, 1997.
27. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ: Differential and persistent expression patterns of CNS gene transfer by an adenoassociated virus (AAV) vector. Brain Res 713:99-107, 1996.
28. Mittereder N, March KL, Trapnell BC: Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 11:7498-7509, 1996.
29. Muhonen MG, Ooboshi H, Welsh MJ, Davidson BL, Heistad DD: Gene transfer to cerebral blood vessels after subarachnoid hemorrhage. Stroke 28:822-828, 1997.
30. Onoue H, Tsutsui M, Smith L, Stelter A, O'Brien T, Katusic ZS: Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29:1959-1966, 1998.
31. Pratt PF, Nithipatikom K, Campbell WB: Simultaneous determination of nitrate and nitrite in biological samples by multichannel flow injection analysis. Anal Biochem 231:383-386, 1995.
32. Rosenblum WI: Tetrahydrobiopterin, a cofactor for nitric oxide synthase, produces endothelium-dependent dilation of mouse pial arterioles. Stroke 28:186-189, 1997.
33. Rosenfeld MR, Bergman I, Schramm L, Griffin JA, Kaplitt MG, Meneses PI: Adeno-associated viral vector gene transfer into leptomeningeal xenografts. J Neurooncol 34:139-144, 1997.
34. Sayama T, Suzuki S, Fukui M: Expression of inducible nitric oxide synthase in rats following subarachnoid hemorrhage. Neurol Res 20:79-84, 1998.
35. Schaack J, Langer S, Guo X: Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase. J Virol 69:3920-3923, 1995.
36. Suzuki Y, Osuka K, Noda A, Tanazawa T, Takayasu M, Shibuya M, Yoshida J: Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage. Neurosurgery 41:807-812, 1997.
37. Thomas JE, Armonda RA, Morrison S, Rosenwasser RH: Preliminary report: Initial observations on the safety and efficacy of intrathecal nitric oxide donors for the treatment of refractory cerebral vasospasm and ischemia in humans. Neurosurgery 43: 670, 1998 (abstr).
38. Thomas JE, Nemirovsky A, Zelman V, Giannotta SL: Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors. Neurosurgery 40: 1245-1249, 1997.
39. Wolf EW, Banerjee A, Soble-Smith J, Dohan FC Jr, White RP, Robertson JT: Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J Neurosurg 89:279-288, 1998.
40. Yamamoto S, Nishizawa S, Yokoyama T, Ryu H, Uemura K: Subarachnoid hemorrhage impairs cerebral blood flow response to nitric oxide but not to cyclic GMP in large cerebral arteries. Brain Res 757:1-9, 1997.